Drug recall · May 22, 2013
Vistide recall
Why: Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
- Lots / codes
Lot #: B120217A, Exp 05/15 - US Distribution
- Quantity
- 3,181 vials
- Company
- Gilead Sciences, Inc., Foster City, CA
- Distribution
- Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.
- Initiated
- January 31, 2013 · Voluntary: Firm initiated
- Classified
- May 16, 2013
- Reported
- May 22, 2013
- Ended
- January 6, 2014
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cidofovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.